The Trigeminal Pathway: Involves transcellular transport to the brainstem and other CNS structures through the largest cranial nerve
FDA's stated reasons: Immunogenicity risk Could trigger immune reactions Impurities Compounded versions may be contaminated Lack of characterization Don't fully understand the molecules No human safety data Haven't been properly tested Reported adverse events Some have documented side effects The DOJ Prosecution: $1.79 Million Forfeiture In a landmark case, the Department of Justice prosecuted Tailor Made Compounding LLC for distributing unapproved peptides including BPC-157
Other platinum-based drugs, such as oxaliplatin and carboplatin, exhibit varying degrees of ototoxicity, with carboplatin being more selective for inner hair cells, while oxaliplatin has a comparatively lower ototoxic potential
Complex concerns such as chronic hair loss or pigmentation disorders may need follow-up visits and diagnostic tests
To address biocompatibility and safety issues, such as dealing with the toxicity of inorganic nanomaterials as they accumulate in the brain, these nanoparticles can be synthesized using more efficient and environmentally friendly processes
A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase